The Effects of Woman Using Rogaine for Men

Step 1

There are many reasons women lose their hair, including menopausal complications and alopecia areata, an inherited condition that results in thinning hair and patchy hair loss. Minoxidil, the active ingredient in Rogaine for men, was approved for women's use at the 2 percent concentration in 1991. The more potent 5 percent dose approved for men in 1997 has yet to gain FDA approval for use in women.

Step 2

Efficacy

Step 1

In a double-blind study conducted by Anne W. Lucky, MD, et. al. and published in the Journal of the American Academy of Dermatology in 2004, the 5 percent treatment group showed statistically significant improvement over the placebo and 2 percent solution groups. The study evaluated effects on three end points: nonvellous hair growth; scalp coverage; and patient perception of hair growth, an analysis of the psychosocial effect of female pattern baldness.

Low Blood Pressure

Step 1

A side effect of any minoxidil for women is slightly lowered blood pressure, and using the 5 percent solution prescribed to men can intensify that affect. Low blood pressure can cause dizziness, fatigue or even fainting upon standing.

Step 2

Unwanted Hair Growth

Step 1

Many women using the five percent Rogain for men experience unwanted hair growth, usually on the face. Some of this is due to the product dripping down to the face after application, but even careful use cannot prevent the effect entirely as the minoxidil enters the blood stream through contact with the scalp.

Pregnancy and Nursing

Step 1

Minoxidil falls into the U.S. Food and Drug Administration's category "C," meaning that in some animal studies, there have been adverse effects on the fetus, but there are no reliable human trials with pregnant women. Category "C" drugs should be avoided by pregnant women unless the benefits far outweigh the risks. Nursing mothers are also advised against using Rogaine in the company's literature as the drug is transmitted through breast milk. The patient should either discontinue Rogaine use or discontinue nursing depending upon treatment need.

REFERENCES & RESOURCES
Load comments
PARTNER & LICENSEE OF THE LIVESTRONG FOUNDATION

Copyright © 2019 Leaf Group Ltd. Use of this web site constitutes acceptance of the LIVESTRONG.COM Terms of Use , Privacy Policy and Copyright Policy . The material appearing on LIVESTRONG.COM is for educational use only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. LIVESTRONG is a registered trademark of the LIVESTRONG Foundation. The LIVESTRONG Foundation and LIVESTRONG.COM do not endorse any of the products or services that are advertised on the web site. Moreover, we do not select every advertiser or advertisement that appears on the web site-many of the advertisements are served by third party advertising companies.